A toolkit to address disparities in digitally enabled oncology trials By Ogkologos - September 5, 2025 452 0 Facebook Twitter Google+ Pinterest WhatsApp An initiative fosters inclusive research by improving patient access and participation in cancer research Source RELATED ARTICLESMORE FROM AUTHOR Significant PFS Improvement with Ibrutinib-Rituximab Compared to Immunochemotherapy in Previously Untreated Patients with Mantle Cell Lymphoma EMA Recommends a Change to the Terms of the Marketing Authorisation for Mosunetuzumab Combining Niraparib with Abiraterone Acetate and Prednisone Significantly Improves rPFS in Patients with mCSPC Harbouring BRCA1/2 or Other HRR Gene Alterations MOST POPULAR Adding Neoadjuvant and Adjuvant Pembrolizumab to Standard Care Significantly Improves EFS... July 7, 2025 Cooperativity of BRAF/MAPK Pathway Inhibition and Immune Checkpoint Blockade in Patients... February 3, 2023 Clinical Trials in Genitourinary Cancers: CheckMate 914, KEYNOTE-992, and KEYNOTE-991 May 20, 2021 November is National Family Caregivers Month November 24, 2020 Load more HOT NEWS Why is Colorectal Cancer Rising Rapidly among Young Adults? Biopsia por aspiración con aguja fina (PAAF): Cómo prepararse y qué... Alternatives for Outdoor Foods New hormone treatment for advanced prostate cancer made available in England
